Les Courchaine received his BS in Cell Biology from the University of Maryland and has been working in Facilities and Engineer roles in support of cell and gene therapy for 23 years. Les began his industry career with Osiris Therapeutics in Baltimore, Maryland, supporting Engineering and Qualification efforts in early application of stem cells that led to approval of Prochymal by Health Canada and Medsafe in New Zealand. He then spent the next 10 years working with various teams on start-up and compliance for biologics facilities, including the successful startup work at the Medimmune Manufacturing Facility in Frederick, Maryland. Subsequently, Les joined Lentigen where he led the engineering, facilities, and Validation efforts that positioned the company for acquisition by Miltenyi Biotec. Following the acquisition, Les successfully led the engineering and validation efforts to achieve GMP authorization for distribution of vector in the German market with continued support of immunotherapy and vector production across Miltenyi Biotec facilities in the US.
From his long career in GMP-compliant facilities, Les brings a broad range of skills and expertise to Vector BioMed, including project management experience and strong understanding of regulatory expectation related to Facility and utility commissioning, cleanroom operations and qualification, Equipment validation, management of maintenance and calibrations programs, and risk assessment practices.
Talk to our team today to learn more about our Lentiviral vector manufacturing solutions. If you are an academic organization, ask for our academic pricing.